Founded in 2015, Senseye Inc. is dedicated to revolutionizing mental health diagnostics through innovative computer programming services. The company's core mission is to provide clinicians with fast, accurate tools to personalize care, starting with PTSD. Senseye's breakthrough diagnostic platform focuses on identifying disruptions in the sympathetic nervous system by analyzing eye movements, thereby establishing a clear baseline and tracking patient outcomes over time.
Senseye has attracted notable attention from key figures in the tech and healthcare industries, though specific names and investors are not publicly disclosed. The company has achieved significant milestones in developing its brain-based diagnostic methodology, positioning itself as a leader in mental health innovation. Senseye's impact is seen in its potential to transform how mental health conditions are diagnosed and managed, offering a more personalized and effective approach to treatment.
